Celltrion USA announced the submission of Biologics License Application to the U.S. Food and Drug Administration for CT-P47, a biosimilar candidate of the reference product ACTEMRA®.
Celltrion USA announced the submission of Biologics License Application to the U.S. Food and Drug Administration for CT-P47, a biosimilar candidate of the reference product ACTEMRA®.